Carbapenem-resistant Acinetobacter baumannii complex in the United States—An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019

Sandra N. Bulens; Davina Campbell; Susannah L. McKay; Nicholas Vlachos; Alex B. Burgin; Mark Burroughs; Jasmine Padila; Julian E. Grass; Jesse T. Jacob; Gillian Smith; Daniel Muleta; Meghan Maloney; Bobbie Macierowski; Lucy E. Wilson; Elisabeth Vaeth; Ruth Lynfield; Sean M. O’Malley; Paula M. Snippes Vagnone; Jennifer L. Dale; Sarah J. Janelle; Christopher A. Czaja; H. Durell Johnson; Erin C. Phipps; Kristina G. Flores; Ghinwa Dumyati; Rebecca Tsay; Zintars G. Beldavs; P. Maureen Cassidy; Amanda Hall; Maroya Spalding Walters; Alice Guh; Shelley S. Magill; Joseph D. Lutgring

doi:10.1016/j.ajic.2024.04.184

Abstract

This is the authors' abstract. We don't add key points for this paper.

Understanding the epidemiology of carbapenem-resistant A. baumannii complex (CRAB) and the patients impacted is an important step toward informing better infection prevention and control practices and improving public health response.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bulens et al. (2024) studied this question.

synapsesocial.com/papers/68e6d04db6db64358764dbed https://doi.org/10.1016/j.ajic.2024.04.184

View Full Paper

Ask AI

Bookmark

Share

Carbapenem-resistant Acinetobacter baumannii complex in the United States—An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019

Abstract

Ask about this paper

Discussion

Cite This Study

Carbapenem-resistant Acinetobacter baumannii complex in the United States—An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading